Phase 3 trials demonstrated ENCELTO significantly slowed macular photoreceptor loss in MacTel patients over 24 months.

Wet age-related macular degeneration causes abnormal blood vessels to leak fluid under the retina, damaging central vision. While there's no cure, treatments can slow progression and help preserve ...

More studies are needed to measure the full effect and safety of red light as an eye therapy for all types of macular degeneration. Red light therapy is a treatment traditionally used for cosmetic ...

In this video, we'll explore the main treatment options for wet age-related macular degeneration. Injections and implants. The most common treatment for wet age-related macular degeneration is eye ...

Biotech company Neurotech Pharmaceuticals this month received regulatory approval for its treatment of a a neurodegenerative ...

Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, announced that the U.S. Food and Drug Administration (FDA), has ...

Clear vision is what allows us to experience the world in vivid detail and navigate our daily lives with ease. But there are hundreds of eye diseases, from common conditions such as cataracts ...

Macular Holes, often due to aging ... requiring steroids to reduce inflammation. Early detection and treatment is the main rule for any of the eye related issues to manage if effectively and ...

Older patients with diabetic macular edema have a weaker response to anti-VEGF treatment, according to a presentation at ...

Age-related macular (AMD) degeneration is a leading cause of vision impairment and blindness in the elderly population. In so ...

MacTel is a rare, progressive eye disease that affects the macula and causes a gradual deterioration in central vision.

Wet AMD in its early stages can be treated with drugs to reduce the formation of new blood vessels, but this treatment is inefficient in cases where blood vessel formation is already in its advanced ...